跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Firazyr - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Firazyr
Approved
STANDARD
Firazyr
Vetter Pharma-Fertigung GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ab71833acf52f805
Company
Vetter Pharma-Fertigung GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
ab71833acf52f805
Drug Approval Philippines Name
Firazyr
Product Name
Firazyr
Registration Number
DR-XY48678
Brand Name
Firazyr
Generic Name
Icatibant
Dosage Form
Solution For Injection (SC)
Dosage Strength
10 mg/mL (30 mg/3 mL)
Manufacturer
Vetter Pharma-Fertigung GmbH & Co. KG
Trader
Germany
Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Issuance Date
29 March 2023
Expiry Date
29 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ab71833acf52f805
Type
Standard
Back to Philippines FDA Approvals